Marinus Pharmaceuticals Inc (MRNS)
1.51
+0.06
(+4.14%)
USD |
NASDAQ |
May 03, 16:00
1.515
0.00 (0.00%)
Pre-Market: 20:00
Marinus Pharmaceuticals Total Liabilities (Quarterly): 154.14M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 154.14M |
| September 30, 2023 | 146.27M |
| June 30, 2023 | 143.86M |
| March 31, 2023 | 141.73M |
| December 31, 2022 | 143.52M |
| September 30, 2022 | 102.84M |
| June 30, 2022 | 104.57M |
| March 31, 2022 | 100.40M |
| December 31, 2021 | 83.35M |
| September 30, 2021 | 80.38M |
| June 30, 2021 | 29.93M |
| March 31, 2021 | 18.52M |
| December 31, 2020 | 13.26M |
| September 30, 2020 | 12.10M |
| June 30, 2020 | 12.30M |
| March 31, 2020 | 13.24M |
| December 31, 2019 | 11.07M |
| September 30, 2019 | 11.73M |
| June 30, 2019 | 12.38M |
| March 31, 2019 | 9.874M |
| December 31, 2018 | 6.909M |
| Date | Value |
|---|---|
| September 30, 2018 | 6.977M |
| June 30, 2018 | 3.667M |
| March 31, 2018 | 1.908M |
| December 31, 2017 | 2.664M |
| September 30, 2017 | 2.557M |
| June 30, 2017 | 5.806M |
| March 31, 2017 | 7.576M |
| December 31, 2016 | 9.968M |
| September 30, 2016 | 11.94M |
| June 30, 2016 | 13.83M |
| March 31, 2016 | 12.22M |
| December 31, 2015 | 12.73M |
| September 30, 2015 | 11.10M |
| June 30, 2015 | 11.16M |
| March 31, 2015 | 11.62M |
| December 31, 2014 | 9.059M |
| September 30, 2014 | 3.335M |
| June 30, 2014 | 5.003M |
| March 31, 2014 | 2.026M |
| December 31, 2013 | 2.366M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
11.07M
Minimum
Dec 2019
154.14M
Maximum
Dec 2023
70.30M
Average
80.38M
Median
Sep 2021
Total Liabilities (Quarterly) Benchmarks
| Ligand Pharmaceuticals Inc | 86.30M |
| Soligenix Inc | 7.275M |
| Actinium Pharmaceuticals Inc | 44.50M |
| Macrogenics Inc | 145.80M |
| ADMA Biologics Inc | 193.98M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 170.91M |
| Shareholders Equity (Quarterly) | 16.76M |
| Debt to Equity Ratio | 4.353 |
| Current Ratio | 4.068 |
| Net Debt Paydown Yield | -0.07% |